VBI Vaccines, Inc. – (VBIV) Trading Up -1.1%
Shares of VBI Vaccines, Inc. – (NASDAQ:VBIV) were up 1.1% during trading on Friday . The stock traded as high as $3.84 and last traded at $3.70, with a volume of 281,307 shares trading hands. The stock had previously closed at $3.74.
The company’s market capitalization is $120.32 million. The company’s 50 day moving average is $3.99 and its 200 day moving average is $4.00.
A hedge fund recently bought a new stake in VBI Vaccines, Inc. – stock. Cambridge Investment Research Advisors Inc. purchased a new stake in VBI Vaccines, Inc. – (NASDAQ:VBIV) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,433,100 shares of the biopharmaceutical company’s stock, valued at approximately $3,497,000. Cambridge Investment Research Advisors Inc. owned approximately 6.09% of VBI Vaccines, Inc. – as of its most recent filing with the SEC.
VBI Vaccines Inc, formerly SciVac Therapeutics Inc, is a biotechnology company. The Company is engaged in developing various technologies that focus on vaccine protection. It has developed an enveloped virus like particle (eVLP) vaccine platform that allows for the design of enveloped VLP vaccines. It is involved in various projects related to human cytomegalovirus (CMV) and other antigens.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.